Wheeler Bio brings biologics drug innovators, discovery CROs, and CDMOs together to solve an outdated industry bottleneck and shorten the time to market for new drugs with a unique partnering model built on shared success and lasting collaborations.
Why we invested:
Bringing life-changing new drugs to market in a timely and affordable manner has never been more challenging or important. Too often, innovators and their outsourcing providers have competing timeline horizons, budget expectations, and business priorities that fail to fully consider all chemistry, manufacturing and control aspects until it is too late. This can result in delayed investigational new drug submissions or clinical hold letters from the FDA.